Search results for: HTA
Filter search results
Are Recommendations for HTA of Gene Therapies Being Achieved?
11 September 2023
…recommendations for the health technology assessment (HTA) of gene therapies are being achieved in nine European countries, Australia, and Canada. Key takeaways Changes to HTA methodologies and evidence generation aimed…
ISPOR Europe Round-up: “Gene Therapies: Where High Promise Meets High Uncertainty, How Should HTA Methodologies Appropriately Value and Enable Access?”
8 December 2022
…and discussed actionable recommendations resulting from an expert roundtable. The report identified four broad categories of challenges faced by gene therapies undergoing health technology assessment (HTA): initial assessment of clinical…
From the Antipodes to the Motherland: Reflections on HTA Decision Makers as Budget Takers and Budget Makers
19 January 2016
…affordability. The seminar concluded with a discussion of the HTA process as an agency problem. The decision-making criteria employed by health technology assessment (HTA) agencies differs between countries. Researchers have…
HTAinSite: Recent Changes in the Database of NICE Decisions
7 June 2012
…including many of the top 20 global pharmaceutical companies. HTAinSite is a collaboration of the OHE, City University London and Abacus International. Visit http://www.HTAinSite.com to view sample reports and subscribe….
OHE at HTAi Oslo: A New Drug Development Paradigm, a Framework for Developing Formularies in MICs, and the Effect of NICE Decisions Abroad
15 June 2015
…new drug development paradigm, and a comparison of EQ-5D-5L and EQ-5D-3L. HTAi’s 12th Annual Meeting, Global Efforts in Knowledge Transfer: HTA to Health Policy and Practice, is scheduled for 15-17…
Spotlight on OHE: Measuring Preferences, HTA Benchmarking, Value-Based Pricing, and Rationing
13 October 2011
…the study’s key conclusions about the interaction between the evolution of health systems and the development of HTA. He argued that as countries develop HTA capability, they should address ‘macro’…
ISPOR Issue Panel Roundup: Are Our HTA Methods Fit for Purpose for Gene Therapies?
6 June 2022
As part of OHE’s presence at ISPOR 2022 in Washington DC, we hosted an issue panel tackling the hot topic of health technology assessment (HTA) of gene therapies. As part…
OHE at HTAi Rome
12 July 2017
The presentations delivered by OHE at the HTAi Annual Meeting, June 2017, are available in this post. A selection of the presentations delivered by OHE at the HTAi Annual Meeting…
How can HTA meet the needs of health system and government decision makers?
4 January 2017
The 2015 meeting of the HTAi Asia Policy Forum meeting was held in Singapore, 29th -30th October 2015. The topic of the meeting was: How can HTA meet the needs…